// App-Quantinova.ai

3507 : Rhamnetin enhances anti-proliferative and apoptotic effects on prostate cancer cells

Researchers

Presenter

  • Riddhi Patel

Principal Investigators

  • Rebecca Pakradooni

  • Christine Oak

  • Natarajan Bhaskaran

  • Sanjeev Shukla

Medical Centers

  • Case Western Reserve University, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase 3

  • Proto-oncogene tyrosine-protein kinase ROS

  • Fibroblast growth factor receptor 1

  • TNF receptor superfamily member 25

  • Klotho

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved